SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated March 10, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on March 7, 2025, pursuant to a non-discretionary agreement with Citigroup Global Markets Limited entered into on February 24, 2025.
Key Financial Metrics and Transaction Details
- Shares Purchased: 500,700 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,497.00 GBp; highest price paid was 1,535.00 GBp.
- Average Price: Volume-weighted average price paid was 1,513.29 GBp.
- Trading Venue: All transactions occurred on the London Stock Exchange (XLON).
- Treasury Holdings: Following this purchase, GSK holds 176,099,345 ordinary shares in treasury.
- Shares Outstanding: 4,139,089,996 ordinary shares are in issue (excluding treasury shares).
- Voting Rights: Total voting rights are 4,139,089,996.
Material Changes and Program Progress
This transaction is part of GSK's existing buyback programme. Since the commencement of the current agreement on February 24, 2025, the company has purchased an aggregate of 7,029,042 ordinary shares. The filing does not provide comparative financial data (revenue, profit, cash flow) as it is a transaction-specific report rather than a periodic financial statement.
Outlook, Risks, and Management Commentary
The filing includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks and uncertainties. These factors are referenced as being described in Item 3.D "Risk factors" of GSK's 2023 Annual Report on Form 20-F and the Q4 2024 Results. No specific new guidance or management commentary regarding operational outlook is provided in this document.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the buyback programme since February 24, 2025 (7,029,042 shares).
- Confirm the updated treasury share count of 176,099,345 shares.
- Note the denominator for shareholder notification thresholds under FCA rules is 4,139,089,996 voting rights.
- Review the specific trade execution prices, which ranged between 1,497.00p and 1,535.00p.